In March, a journal published a paper about blood sugar levels in newborns that caused an immediate outcry from outside experts, who were concerned it contained a sentence that could be potentially harmful if misinterpreted by doctors.
Recently, the journal explained — in impressive detail — why it’s not retracting the paper. That, of course, gives readers the ability to form their own opinions. After seeing the pros and cons, let us know if you think the journal made the right call in a poll at the bottom of the story.
Six months ago, the media was ablaze with the findings of a new paper, showing that nearly six percent of cancer cases are caused, at least in part, by obesity and diabetes. But this week, the journal retracted that paper — and replaced it with a revised version.
The new paper doesn’t change the main findings much — the share of all cancers attributable to diabetes and obesity changed from 5.6% to 5.7%, which wouldn’t change any headlines about the original paper. But soon after the paper was published, a group of researchers noticed the authors’ mistake — which was significant enough to prompt the journal to retract the paper entirely, and swap it with a new one.
Recently, a rash of news outlets posted concerns that canned tuna and other products may contain potentially dangerous levels of zinc. They were all wrong.
News outlets such as The Daily Mail and The Sun reported findings from a recent study, which showed that canned foods such as tuna may contain 100 times the daily limit of zinc — raising concerns about how such huge doses of the mineral could be causing digestion problems. The last author of the study told Retraction Watch the paper is going to be retracted, because the authors made a fundamental error calculating the amount of zinc present in canned foods.
Here’s something we don’t see that often — authors retracting one of their articles because it included new data.
But that is the case with a 2017 review exploring the potential genetic and hormonal underpinnings of gender identity. The authors Rosa Fernández García and Eduardo Pásaro Mendez told Retraction Watch that they asked bioethics journal Cuadernos de Bioética to withdraw their review after realizing it “indirectly” mentioned some of their unpublished work. According to García, the authors had hoped to publish the new data in a scientific paper before the review came out, but the review ended up being published first.
Researchers have retracted and replaced a 2014 paper in JAMA Psychiatry, exploring a new way to classify attention deficit hyperactivity disorder (ADHD) in children, after discovering errors in the data.
A researcher has retracted two 2014 papers, after discovering they had not gone through the proper approval process before being submitted.
The papers were part of a collaboration funded by the U.S. National Institutes of Health, which focused on solving protein structures. Adam Godzik, the senior author, told Retraction Watch that all papers had to be approved by a special committee before being submitted to a journal. Given the scale of the collaboration, the committee for the Joint Center for Structural Genomics (JCSG) would assess whether researchers who had made a previous contribution to the work should be added as authors.
Originally published June 17, 2016, the paper was retracted Jan. 15. Led by corresponding author Xavier Altafaj, of the University of Barcelona (UB) and Bellvitge Biomedical Research Institute (IDIBELL), researchers described using an amino acid, D-serine, to treat a child with a rare genetic disorder that affects neurons.
According to the notice, the researchers did use D-serine in lab work used as proof-of-concept; however, when it came time to try it in the patient, as a result of a “communication error:”